Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.
about
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung CancerAn updated meta-analysis of 23 case-control studies on the association between miR-34b/c polymorphism and cancer riskPredictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients.Predictive value of XPG rs2296147T>C polymorphism on clinical outcomes of cancer patients.Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems.
P2860
Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Predictive assessment in pharm ...... h platinum-based chemotherapy.
@ast
Predictive assessment in pharm ...... h platinum-based chemotherapy.
@en
type
label
Predictive assessment in pharm ...... h platinum-based chemotherapy.
@ast
Predictive assessment in pharm ...... h platinum-based chemotherapy.
@en
prefLabel
Predictive assessment in pharm ...... h platinum-based chemotherapy.
@ast
Predictive assessment in pharm ...... h platinum-based chemotherapy.
@en
P2093
P2860
P356
P1433
P1476
Predictive assessment in pharm ...... h platinum-based chemotherapy.
@en
P2093
Qiang Weng
Yingying Han
Zhengrong Yuan
P2860
P2888
P356
10.1038/SREP16482
P407
P577
2015-11-20T00:00:00Z